{"id":"W2049103239","doi":"10.1002/jso.21160","title":"Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665","year":2008,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; GiST; Imatinib mesylate; Clinical endpoint; Stromal tumor; Oncology; Neoadjuvant therapy; Prospective cohort study; Surgery; Adjuvant therapy; Internal medicine; Imatinib; Clinical trial; Chemotherapy; Stromal cell; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002036215,0.00169454,0.001263685,0.0003445952,0.000295899,0.0006484981,0.0005074658,0.0008673886,0.003025722],"category_scores_gemma":[0.0009950437,0.0004464583,0.0009173848,0.0003343028,0.0008802279,0.0004609349,0.0003636852,0.002183268,0.0006616722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004529322,"about_ca_system_score_gemma":0.001105841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005543748,"about_ca_topic_score_gemma":0.001275094,"domain_scores_codex":[0.9993936,0.0003874459,0.00002933482,0.00006223095,0.00004257783,0.00008489624],"domain_scores_gemma":[0.9991692,0.00016685,0.0002014838,0.00006785875,0.00003503094,0.000359526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8688325,0.03868914,0.01105354,0.000508872,0.0007086136,0.0002928158,0.000283821,0.001578692,0.02362287,0.0001711731,0.001817966,0.05244],"study_design_scores_gemma":[0.597986,0.3837559,0.01224908,0.00003714551,0.0002823041,0.0002935758,0.00004465061,0.0008188127,0.002903498,0.0001102146,0.001496768,0.00002202693],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964961,0.0008225829,0.0003004904,0.0002484742,0.00005201016,0.001029003,0.0003556674,0.00003236509,0.0006631555],"genre_scores_gemma":[0.9916109,0.0009650216,0.001297307,0.0005675848,0.0001564164,0.001861078,0.001590395,0.00001757786,0.001933609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003025722,"threshold_uncertainty_score":0.01076865,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05635592054638017,"score_gpt":0.3749986522691786,"score_spread":0.3186427317227984,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}